skip to main |
skip to sidebar
Announcing the CDER SBIA REdI: Generic Drugs Forum April 11-12, 2018
CDER Small Business and Industry Assistance (SBIA) invites you to the free two-day FDA led Regulatory Education for Industry (REdI): Generic Drugs Forum 2018. Join us to learn from and interact with FDA subject matter experts involved in the Generic Drug Review Program.
Our agenda covers over 20 topics, including a Pharmaceutical Quality Update; Determining Whether to Submit an ANDA or a 505(b)(2) Application; Laboratory Science to Support Risk-Based Quality Assessments; and more…
Keynote speaker: Dr. Kathleen Uhl, Director of the Office of Generic Drugs.
What: SBIA REdI Generic Drugs Forum
When: April 11-12, 2018
Where: On-site in Silver Spring, MD,
or virtually online via Adobe Connect.
Advance registration is required.
We ask that you please honor your registration commitment to help us plan this conference efficiently. If you need to change your registration status, please email us at cancellation@SBIAevents.com.
This conference has been pre-approved by RAPS as eligible for up to
12 credits towards a participant’s RAC recertification upon full completion.
A MUST ATTEND event for all professionals involved with the generic drug industry!
No hay comentarios:
Publicar un comentario